John P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL, USA.
John T. McDonald Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, FL, USA.
Sci Rep. 2019 Aug 12;9(1):11621. doi: 10.1038/s41598-019-48186-1.
Carotid intima-media thickness (cIMT) is a subclinical marker for atherosclerosis. Previously, we reported a quantitative trait locus (QTL) for total cIMT on chromosome 14q and identified PRiMA1, FOXN3 and CCDC88C as candidate genes using a common variants (CVs)-based approach. Herein, we further evaluated the genetic contribution of the QTL to cIMT by resequencing. We sequenced all exons within the QTL and genomic regions of PRiMA1, FOXN3 and CCDC88C in Dominican families with evidence for linkage to the QTL. Unrelated Dominicans from the Northern Manhattan Study (NOMAS) were used for validation. Single-variant-based and gene-based analyses were performed for CVs and rare variants (RVs). The strongest evidence for association with CVs was found in PRiMA1 (p = 8.2 × 10 in families, p = 0.01 in NOMAS at rs12587586), and in the five-gene cluster SPATA7-PTPN21-ZC3H14-EML5-TTC8 locus (p = 1.3 × 10 in families, p = 0.01 in NOMAS at rs2274736). No evidence for association with RVs was found in PRiMA1. The top marker from previous study in PRiMA1 (rs7152362) was associated with fewer atherosclerotic events (OR = 0.67; p = 0.02 in NOMAS) and smaller cIMT (β = -0.58, p = 2.8 × 10 in Family). Within the five-gene cluster, evidence for association was found for exonic RVs (p = 0.02 in families, p = 0.28 in NOMAS), which was enriched among RVs with higher functional potentials (p = 0.05 in NOMAS for RVs in the top functional tertile). In summary, targeted resequencing provided validation and novel insights into the genetic architecture of cIMT, suggesting stronger effects for RVs with higher functional potentials. Furthermore, our data support the clinical relevance of CVs associated with subclinical atherosclerosis.
颈动脉内膜中层厚度(cIMT)是动脉粥样硬化的亚临床标志物。此前,我们曾报道过 14q 染色体上与总 cIMT 相关的数量性状基因座(QTL),并使用基于常见变异(CVs)的方法鉴定了 PRiMA1、FOXN3 和 CCDC88C 为候选基因。在此,我们通过重测序进一步评估了该 QTL 对 cIMT 的遗传贡献。我们对 QTL 内的所有外显子以及 PRiMA1、FOXN3 和 CCDC88C 的基因组区域进行了测序,这些区域在具有与 QTL 连锁证据的多米尼加家庭中。来自北方曼哈顿研究(NOMAS)的无关多米尼加人被用于验证。对 CVs 和稀有变异(RVs)进行了基于单变体和基于基因的分析。在 PRiMA1 中发现了与 CVs 最强关联的证据(家庭中 p = 8.2×10,NOMAS 中 p = 0.01,rs12587586),在 SPATA7-PTPN21-ZC3H14-EML5-TTC8 基因座的五个基因簇中也发现了关联(家庭中 p = 1.3×10,NOMAS 中 p = 0.01,rs2274736)。在 PRiMA1 中未发现与 RVs 相关的证据。先前在 PRiMA1 中研究的最高标记物 rs7152362 与较少的动脉粥样硬化事件相关(NOMAS 中 OR = 0.67;p = 0.02),与较小的 cIMT 相关(β = -0.58,p = 2.8×10,家庭)。在五个基因簇中,发现了外显子 RVs 的关联证据(家庭中 p = 0.02,NOMAS 中 p = 0.28),这在功能潜力较高的 RVs 中更为丰富(NOMAS 中 RVs 在最高功能三分位的 p = 0.05)。总之,靶向重测序为 cIMT 的遗传结构提供了验证和新的见解,表明具有较高功能潜力的 RVs 具有更强的效应。此外,我们的数据支持与亚临床动脉粥样硬化相关的 CVs 的临床相关性。